Evidence map›Paper›PMID 18384229›Full record

ArticlePLoS medicine2008

Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum.

Natalie J Garton, Simon J Waddell, Anna L Sherratt, Su-Min Lee, Rebecca J Smith, Claire Senner, Jason Hinds, Kumar Rajakumar, Richard A Adegbola, Gurdyal S Besra and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 232 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
232citing papers in PubMed, 1 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

232 citing papers in PubMed, 1 synthesis or guideline pooled it, 440 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genome-wide transcriptional landscape ofFrontiers in immunology · 2026
    Article
  10. Transcript-Capture sequencing enriches mRNA ofbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Zinc-limitedInfection and immunity · 2025
    Article
  15. Article
  16. Building Spatiotemporal Understanding ofACS infectious diseases · 2025
    Review
  17. Emergence of antibiotic-specificAntimicrobial agents and chemotherapy · 2025
    Article
  18. Frontiers in cellular and infection microbiology · 2025
    Article
  19. Review
  20. Can lipid body-positive rates ofFrontiers in immunology · 2025
    Article

172 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Natalie J GartonDepartment of Infection, Immunity and Inflammation, University of Leicester Medical School, Leicester, United Kingdom.
Simon J Waddell
Anna L Sherratt
Su-Min Lee
Rebecca J Smith
Claire Senner
Jason Hinds
Kumar Rajakumar
Richard A Adegbola
Gurdyal S Besra
Philip D Butcher
Michael R Barer
St George's, University of London · GBNational Health Service · GBNIHR Leicester Biomedical Research Centre · GBUniversity of Leicester · GBMRC Unit the Gambia · GMUniversity of Birmingham · GB

Funding

Medical Research Council G0200510Medical Research Council G0501435NIAID NIH HHS HHSN266200400091CNIAID NIH HHS N01 AI040091Wellcome Trust 080039
6 · The paper itself

Abstract

backgroundTuberculous sputum provides a sample of bacilli that must be eliminated by chemotherapy and that may go on to transmit infection. A preliminary observation that Mycobacterium tuberculosis cells contain triacylglycerol lipid bodies in sputum, but not when growing in vitro, led us to investigate the extent of this phenomenon and its physiological basis. METHODS AND

findingsMicroscopy-positive sputum samples from the UK and The Gambia were investigated for their content of lipid body-positive mycobacteria by combined Nile red and auramine staining. All samples contained a lipid body-positive population varying from 3% to 86% of the acid-fast bacilli present. The recent finding that triacylglycerol synthase is expressed by mycobacteria when they enter in vitro nonreplicating persistence led us to investigate whether this state was also associated with lipid body formation. We found that, when placed in laboratory conditions inducing nonreplicating persistence, two M. tuberculosis strains had lipid body levels comparable to those found in sputum. We investigated these physiological findings further by comparing the M. tuberculosis transcriptome of growing and nonreplicating persistence cultures with that obtained directly from sputum samples. Although sputum has traditionally been thought to contain actively growing tubercle bacilli, our transcript analyses refute the hypothesis that these cells predominate. Rather, they reinforce the results of the lipid body analyses by revealing transcriptional signatures that can be clearly attributed to slowly replicating or nonreplicating mycobacteria. Finally, the lipid body count was highly correlated (R(2) = 0.64, p < 0.03) with time to positivity in diagnostic liquid cultures, thereby establishing a direct link between this cytological feature and the size of a potential nonreplicating population.

conclusionAs nonreplicating tubercle bacilli are tolerant to the cidal action of antibiotics and resistant to multiple stresses, identification of this persister-like population of tubercle bacilli in sputum presents exciting and tractable new opportunities to investigate both responses to chemotherapy and the transmission of tuberculosis.

Indexed as

GambiaGene Expression ProfilingHumansLipidsMycobacterium tuberculosisOligonucleotide Array Sequence AnalysisSputumTriglyceridesTuberculosis, PulmonaryLipidsTriglycerides

Identifiers

PMID18384229
PMCPMC2276522
OpenAlexW2170535863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.